Last deal

$175K

Amount

Pre-Seed

Stage

20.03.2023

Date

3

all rounds

$300K

Total amount

General

About Company
EndoShunt Medical provides a medical device for targeted hemorrhage control in emergency situations.

Industry

Sector :

Subsector :

Keywords :

Also Known As

REBy Medical

founded date

01.01.2022

Number of employees

Company Type

For Profit

Last funding type

Pre-Seed

IPO status

Private

Description

The Massachusetts-based company, founded in 2022, offers an innovative medical device that targets hemorrhage control in emergency situations. The EndoShunt device is designed to be easily inserted into the body and can be used to quickly stop bleeding in critical situations. The device is expected to have a significant impact on emergency medical care, particularly in situations where traditional methods of hemorrhage control are not effective. With its cutting-edge technology and commitment to improving patient outcomes, EndoShunt Medical is poised to make a major impact in the medical device industry.
Contacts